Press release
Heart Failure Drugs Market Size Worth USD 21.63 Billion in 2032 | Emergen Research
Heart Failure Drugs Market
Key Drivers of Market Growth
1. Impact of Aging on Heart Failure: The rising number of elderly individuals is a significant factor propelling market revenue growth. With aging, the heart's pumping capacity may diminish, leading to heart failure. Reports indicate that 25% of adults over the age of 85 are affected by heart failure. Individualized treatment plans are essential for senior citizens with heart failure, considering their unique medical conditions.
2. Impact of Lifestyle Factors: Increasing risk factors associated with lifestyle choices such as substance abuse, smoking, depression, obesity, and physical inactivity are contributing to the rise in heart failure cases. Lifestyle modifications, including regular exercise and smoking cessation, are crucial for promoting heart health and preventing related consequences.
Click To get SAMPLE PDF (Including Full TOC, Graphs & Charts, Table & Figures)@ https://www.emergenresearch.com/request-sample/2755
Market Segment Insights
1. Heart Failure Drugs Type Insights:
• Dominance of Beta Blockers Segment: Beta blockers, known for their ability to increase long-term survival rates of patients, accounted for the largest market share in 2022. These medications play a crucial role in treating cardiovascular diseases by lowering heart rate and preventing the heart from working too hard.
• Rapid Growth of ACE Inhibitors Segment: ACE inhibitors have demonstrated efficacy in addressing the underlying mechanisms of heart failure, thereby driving rapid revenue growth. These medications block an enzyme in the Renin Angiotensin Aldosterone System (RAAS), leading to symptom alleviation and increased survival rates.
2. Heart Failure Drugs Stage of Heart Failure Insights:
• Dominance of Chronic Segment: The chronic segment accounted for the largest market share in 2022, driven by an increase in risk factors associated with lifestyle choices. Chronic heart failure, characterized by the heart's persistent incapacity to pump enough blood, requires long-term management and treatment.
• Largest Growth of Acute Segment: The acute segment is expected to register robust growth, attributed to the increasing recognition of the life-threatening nature of acute heart failure. Acute heart failure refers to sudden deterioration in the heart's capacity to pump or fill with enough blood, necessitating rapid and effective treatment options.
Request For An Discount@ https://www.emergenresearch.com/request-discount/2755
3. Heart Failure Drugs Application Insights:
• Dominance of Capsule Segment: The capsule segment is expected to register rapid growth due to its convenience and patient preference for oral administration. Heart failure medication capsules offer an easy-to-administer treatment option for patients.
• Largest Growth of Injection Segment: The injection segment accounted for the largest market share in 2022, driven by the effectiveness of injectable medications, especially in situations where oral medications are insufficient or have significant side effects.
Heart Failure Drugs Top Companies and Competitive Landscape
The global heart failure drugs market is fairly fragmented, with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective heart failure drugs solutions.
Some major players included in the global heart failure drugs market report are:
• Amgen Inc.
• AstraZeneca
• Bayer AG
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• Bausch Health Companies Inc.
• Cardurion Pharmaceuticals
• Cardior Pharmaceuticals GmbH
• CYTOKINETICS, INC.
• Janssen Global Services, LLC
• Lilly
• Exelixis, Inc.
• Gilead Sciences, Inc.
• GSK plc
• Merck & Co., Inc.
• Mylan N.V.
• Novartis AG
• Pfizer Inc.
• Sanofi
• Teva Pharmaceutical Industries Ltd.
Buy the full research report at @ https://www.emergenresearch.com/select-license/2755
Heart Failure Drugs Latest Industry News
• On 29 May 2023, Lexicon Pharmaceuticals announced the approval of its Inpefa medication to treat cardiac failure by the US Food and Drug Administration (FDA). A once-daily oral pill called Inpefa is prescribed as an inhibitor of type 1 and type 2 Sodium-Glucose Co-Transporters (SGLT1). The objective is to lower the risk of cardiac failure hospitalization, urgent heart failure visits, and cardiovascular mortality. Adults with heart failure, chronic renal disease, type 2 diabetes, and other cardiovascular risk factors can take the pill.
Heart Failure Drugs Market Segment Analysis
For the purpose of this report, Emergen Research has segmented global heart failure drugs market on the basis of type, application, stage of heart failure, distribution channel, end-use, and region:
• Type Outlook (Revenue, USD Billion; 2019-2032)
o Beta Blockers
o ACE Inhibitors
o Angiotensin-receptor neprilysin inhibitors
o Angiotensin receptor blockers
o Diuretics
o Others
• Application Outlook (Revenue, USD Billion; 2019-2032)
o Injection
o Capsule
o Tablets
o Others
• Stage Of Heart Failure Outlook (Revenue, USD Billion; 2019-2032)
o Acute
o Chronic
• Distribution Channel Outlook (Revenue, USD Billion; 2019-2032)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• End-Use Outlook (Revenue, USD Billion; 2019-2032)
o Hospitals
o Specialty Centers
o Others
Interested in knowing more relevant information? Click here: https://www.emergenresearch.com/industry-report/heart-failure-drugs-market
Look Over transcripts provided by Emergen Research
3D printed metal market
https://prtimes.jp/main/html/rd/p/000000103.000082259.html
plastic waste management market
https://prtimes.jp/main/html/rd/p/000000102.000082259.html
Insulation market
https://prtimes.jp/main/html/rd/p/000000101.000082259.html
Thermal Interface Materials Market
https://prtimes.jp/main/html/rd/p/000000100.000082259.html
nanopharmaceutical market
https://prtimes.jp/main/html/rd/p/000000099.000082259.html
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Heart Failure Drugs Market Size Worth USD 21.63 Billion in 2032 | Emergen Research here
News-ID: 3473678 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Heart
Heart Healthy Foods and Supplements vs Heart Conditions
Heart conditions remain a major health concern worldwide, but the good news is that specific heart healthy foods and supplements can significantly improve cardiovascular health.
Scientific research has demonstrated that certain foods, nutrients and supplements support heart function, reduce inflammation, and lower the risk of heart disease.
Top Heart Healthy Foods
Fatty Fish - Salmon, mackerel, and sardines are rich in omega-3 fatty acids, which help lower blood pressure and reduce inflammation. A…
Centrifugal Heart Pumps Market | Abbott Laboratories, Abiomed, Berlin Heart, Car …
The global centrifugal heart pumps market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the centrifugal heart pumps market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr
When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue…
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH…
HEART PUMP DEVICES Market 2020 | SWOT Analysis By Top Players Abbott Laboratorie …
A detailed study on HEART PUMP DEVICES Market formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in…
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot
Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after…
